LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/2/2020ACC: 0001209191-20-033455
Officer· Chief Financial Officer
Since Jun 2018
+84.00
Net shares
Net buyer
$1.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
84.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+42.00
Price / share
$27.77
Trade value
$1.17K
% of position
1.6%
5/29/2020
2.67K→2.71K
Total
Net shares
+42.00
Net value
$1.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2020 | A · Award | +42.00 | $27.77 | $1.17K | 1.6% | 2.67K | 2.71K |
| Total | +42.00 | $1.17K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
42.00 shares
Shares
+42.00
Strike price
32.67
Held after
42.00
Exercisable
—
5/29/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock42.00 shares | 5/29/2020 | A · Award | +42.00 | 32.67 | — | 42.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned14.08M
Total
14.08M indirect14.08M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.08M | Indirect |
| Total | 14.08M | 14.08M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported